Tinavi Medical Technologies Co Ltd Capital Reinvestment Ratio
Tinavi Medical Technologies Co Ltd capital reinvestment ratio. Tinavi Medical Technologies Co Ltd (688277) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥24.50 Million) in capital expenditures (CN¥928.31K). Check how aggressively does Tinavi Medical Technologies Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tinavi Medical Technologies Co Ltd (2015–2019)
Capital reinvestment ratio of Tinavi Medical Technologies Co Ltd from 2015 to 2019. This chart tracks Tinavi Medical Technologies Co Ltd's Capital Reinvestment Ratio across 4 annual periods. Also explore 688277 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tinavi Medical Technologies Co Ltd Capital Reinvestment Ratio by Year (2015–2019)
Tinavi Medical Technologies Co Ltd capital reinvestment ratio by year from 2015 to 2019. For the full cash flow conversion analysis, see 688277 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.98x | CN¥20.53 Million | CN¥20.17 Million | ▼ -52.8% |
| 2018 | 2.08x | CN¥13.15 Million | CN¥27.36 Million | ▲ +89.9% |
| 2017 | 1.10x | CN¥5.73 Million | CN¥6.28 Million | ▲ +2709.1% |
| 2015 | 0.04x | CN¥41.82 Million | CN¥1.63 Million | — |